Your browser doesn't support javascript.
loading
Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.
Bellanné-Chantelot, Christine; Schmaltz-Panneau, Barbara; Marty, Caroline; Fenneteau, Odile; Callebaut, Isabelle; Clauin, Séverine; Docet, Aurélie; Damaj, Gandhi-Laurent; Leblanc, Thierry; Pellier, Isabelle; Stoven, Cécile; Souquere, Sylvie; Antony-Debré, Iléana; Beaupain, Blandine; Aladjidi, Nathalie; Barlogis, Vincent; Bauduer, Frédéric; Bensaid, Philippe; Boespflug-Tanguy, Odile; Berger, Claire; Bertrand, Yves; Carausu, Liana; Fieschi, Claire; Galambrun, Claire; Schmidt, Aline; Journel, Hubert; Mazingue, Françoise; Nelken, Brigitte; Quah, Thuan Chong; Oksenhendler, Eric; Ouachée, Marie; Pasquet, Marlène; Saada, Véronique; Suarez, Felipe; Pierron, Gérard; Vainchenker, William; Plo, Isabelle; Donadieu, Jean.
Afiliação
  • Bellanné-Chantelot C; Department of Genetics, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France.
  • Schmaltz-Panneau B; INSERM UMR1170 and.
  • Marty C; INSERM UMR1170 and.
  • Fenneteau O; University Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Callebaut I; INSERM UMR1170 and.
  • Clauin S; University Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Docet A; Laboratory of Hematology, Robert Debré Hospital, AP-HP, Paris, France.
  • Damaj GL; CNRS UMR7590, Sorbonne Universités, Université Pierre et Marie Curie-Paris 6-MNHN-IRD-IUC, Paris, France.
  • Leblanc T; Department of Genetics, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France.
  • Pellier I; Department of Genetics, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France.
  • Stoven C; Department of Hematology, Centre Hospitalier Universitaire (CHU), Faculté de Médecine, University of Normandie Caen, Caen, France.
  • Souquere S; Department of Pediatric Hematology and Immunology, Robert Debré Hospital, AP-HP, Paris, France.
  • Antony-Debré I; Department of Pediatric Hematology, Immunology and Oncology, CHU, Angers, France.
  • Beaupain B; Department of Pediatrics, CHU La Réunion, Groupe Hospitalier Sud Réunion, France.
  • Aladjidi N; CNRS UMR9196, Gustave Roussy, Villejuif, France.
  • Barlogis V; INSERM UMR1170 and.
  • Bauduer F; University Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Bensaid P; French Registry of Chronic Neutropenia, Trousseau Hospital, Paris, France.
  • Boespflug-Tanguy O; Unit of Pediatric Hematology, Centre d'Investigation Clinique 1401 INSERM Centre d'Investigation Clinique Plurithématique, CHU Bordeaux, France.
  • Berger C; Department of Pediatric Hematology, Timone Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
  • Bertrand Y; Centre Hospitalier Côte Basque, Bayonne, France.
  • Carausu L; Department of Pediatrics, Centre Hospitalier Argenteuil, Argenteuil, France.
  • Fieschi C; Child Neurology and Metabolic Disorders Department, Robert Debré Hospital, AP-HP, Paris, France.
  • Galambrun C; Department of Pediatric Hematology and Oncology, CHU, Saint-Etienne, France.
  • Schmidt A; Institut of Pediatric Hematology and Oncology, Lyon, France.
  • Journel H; Department of Pediatric Hematology and Oncology, CHU, Brest, France.
  • Mazingue F; Department of Clinical Immunology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Nelken B; Department of Pediatric Hematology, Timone Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
  • Quah TC; Department of Hematology, CHU, Angers, France.
  • Oksenhendler E; INSERM U892/CNRS 6299, Angers University, Angers, France.
  • Ouachée M; Department of Genetics, Bretagne-Atlantique Hospital, Vannes, France.
  • Pasquet M; Department of Pediatric Hematology and Oncology, CHRU, Lille, France.
  • Saada V; Department of Pediatric Hematology and Oncology, CHRU, Lille, France.
  • Suarez F; Department of Pediatrics, National University Hospital, Singapore.
  • Pierron G; Department of Clinical Immunology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Vainchenker W; Department of Pediatric Hematology and Immunology, Robert Debré Hospital, AP-HP, Paris, France.
  • Plo I; Institut of Pediatric Hematology and Oncology, Lyon, France.
  • Donadieu J; Department of Pediatric Hematology and Oncology, CHU, Toulouse, France.
Blood ; 132(12): 1318-1331, 2018 09 20.
Article em En | MEDLINE | ID: mdl-29914977
ABSTRACT
Congenital neutropenias (CNs) are rare heterogeneous genetic disorders, with about 25% of patients without known genetic defects. Using whole-exome sequencing, we identified a heterozygous mutation in the SRP54 gene, encoding the signal recognition particle (SRP) 54 GTPase protein, in 3 sporadic cases and 1 autosomal dominant family. We subsequently sequenced the SRP54 gene in 66 probands from the French CN registry. In total, we identified 23 mutated cases (16 sporadic, 7 familial) with 7 distinct germ line SRP54 mutations including a recurrent in-frame deletion (Thr117del) in 14 cases. In nearly all patients, neutropenia was chronic and profound with promyelocytic maturation arrest, occurring within the first months of life, and required long-term granulocyte colony-stimulating factor therapy with a poor response. Neutropenia was sometimes associated with a severe neurodevelopmental delay (n = 5) and/or an exocrine pancreatic insufficiency requiring enzyme supplementation (n = 3). The SRP54 protein is a key component of the ribonucleoprotein complex that mediates the co-translational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER). We showed that SRP54 was specifically upregulated during the in vitro granulocytic differentiation, and that SRP54 mutations or knockdown led to a drastically reduced proliferation of granulocytic cells associated with an enhanced P53-dependent apoptosis. Bone marrow examination of SRP54-mutated patients revealed a major dysgranulopoiesis and features of cellular ER stress and autophagy that were confirmed using SRP54-mutated primary cells and SRP54 knockdown cells. In conclusion, we characterized a pathological pathway, which represents the second most common cause of CN with maturation arrest in the French CN registry.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Pancreática Exócrina / Doenças da Medula Óssea / Partícula de Reconhecimento de Sinal / Estresse do Retículo Endoplasmático / Lipomatose / Mutação / Neutropenia Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Pancreática Exócrina / Doenças da Medula Óssea / Partícula de Reconhecimento de Sinal / Estresse do Retículo Endoplasmático / Lipomatose / Mutação / Neutropenia Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França